New Four-Drug combo aims to tackle tough liver cancer cases
NCT ID NCT07350070
Summary
This study is testing a new combination treatment for people with advanced liver cancer (hepatocellular carcinoma) who also have high blood pressure in their liver (portal hypertension) due to cirrhosis. The treatment combines a minimally invasive procedure (TACE) with three drugs: an immunotherapy (tislelizumab), a targeted cancer drug (lenvatinib), and a blood pressure medication (carvedilol). The goal is to see if this four-part approach can safely shrink tumors while also managing the complications of cirrhosis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Hepatobiliary and Pancreatic Oncology
Fuzhou, Fujian, China
Contact Email: •••••@•••••
-
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Contact Email: •••••@•••••
-
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hubei Province Tahe Hospital
Taihe, Hubei, China
Contact
-
Organ Transplant Department,Qilu Hospital, Cheeloo College of Medicine, Shandong University,
Jinan, Shandong, 250012, China
Contact Email: •••••@•••••
-
Qingdao University Affiliated Hospital
Qingdao, Shandong, China
Contact
-
Shandong First Medical University Affiliated Provincial Hospital
Jinan, Shandong, China
Contact
Conditions
Explore the condition pages connected to this study.